Enliven Therapeutics ELVN Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Enliven Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's software and technology licenses, net?
- Enliven Therapeutics (ELVN) reported software and technology licenses, net of $1.19M in Q1 2026.
- How has Enliven Therapeutics's software and technology licenses, net changed year-over-year?
- Enliven Therapeutics's software and technology licenses, net decreased by 83.5% year-over-year, from $7.2M to $1.19M.
- What is the long-term trend for Enliven Therapeutics's software and technology licenses, net?
- Over 5 years (2020 to 2025), Enliven Therapeutics's software and technology licenses, net has grown at a 49.4% compound annual growth rate (CAGR), from $88K to $656K.